Welcome to MyIDSA

Welcome to MyIDSA, IDSA’s Member-Only Community! Connect with Colleagues, Share Resources, Start or Join a Lively Discussion. Join us…It’s Infectious!


Recent Discussions

  • Posted in: IDea Exchange

    The Physician Compare Preview Period is Here On October 18, 2017, the Physician Compare 30-day preview period will officially open. Clinicians and groups will have the opportunity to preview their 2016 performance information ...

  • Posted in: IDea Exchange

    I have an interesting collection of cases with respect to probiotic use. I have had 2 patients in the past several years with intravascular  infection due to Lactobacillus rhamnosus . One had aortic valve endocarditis and took probiotics on advice from ...

  • Posted in: IDea Exchange

    Hello everyone, I am currently developing my institution's first issue of an Antimicrobial Stewardship Newsletter to be published during U.S. Antibiotic Awareness Week on November 13, 2017. Would anyone be willing to share any examples of their ...

New Guidelines Update

Healthcare-Associated Ventriculitis and Meningitis

Image Credit: National Library of Medicine

Practice Guidelines

Member Spotlight

Sophia Koo, MD, SM, FIDSA has been selected as a semifinalist in the first round of the U.S. Department of Health and Human Services (HHS) Antimicrobial Resistance Diagnostic Challenge, a $20 million federal prize competition seeking innovative, rapid point-of-care laboratory diagnostic tests to combat the development and spread of drug resistant bacteria. Dr. Koo will receive $50,000 to develop her concept, “Breath volatile metabolites for the rapid identification of pneumonia etiology,” into a prototype. The proposal outlines a novel approach to community acquired pneumonia (CAP) diagnosis based on distinct differences in the breath volatile metabolite profiles of patients with bacterial vs. viral pneumonia.

Dr. Koo is with Harvard Medical and the Dana-Farber Cancer Institute and is a member of IDSA’s Diagnostics Committee.


  • Will the World's Most Worrying Flu Virus Go Pandemic?

    The Centers for Disease Control and Prevention (CDC) keeps a Most Wanted list for flu viruses.

  • New diarrhea guidelines stress implications of molecular tests

    New guidelines for diagnosing and managing infectious diarrhea stress that improved tests are capable of detecting multiple organisms in the ...

Help attract the best and brightest to the field of infectious diseases.

IDSA Education and Research

Upcoming Events

  • Wednesday

    Infectious Diseases in Primary Care

    Wednesday, October 25 - Friday, October 27, 2017
    This acclaimed course provides a comprehensive ID update. Led by Harvard Medical School's leading ID faculty and clinicians, this program provides guidance to improve the diagnosis, prevention, and treatment of infectious diseases. Participants learn the practice implications of important new innovations and ensure that their ability to address ID challenges is fully current.
    Boston, MA

IDSA has been important in my career in infectious disease. IDSA also plays a big role in advocacy and drawing attention to key issues. It's exciting to be a part of that and feel that I have an avenue for my voice to be heard.
Ingrid Bassett, MD, MPH, FIDSA
The idea that I could link epidemiology with my fundamental knowledge of how microorganisms work, along with diagnostic microbiology...this is an amazing way to put the pieces of the puzzles together about how infectious diseases work in human beings.
Lucy Tompkins, MD, PhD, FIDSA
I always like mystery stories growing up and you have to be very astute...You have to look at the symptoms, the geography, the home and social situation to solve the mystery of their problem.
Susan Bleasdale, MD
You can take a patient in front of you, and within a short amount of time with your clinical care, have an enormous impact.
John Lynch, MD, MPH
Understanding the pathogenesis of infectious diseases requires a knowledge of pathology, immunology, especially microbiology. The discipline allows practitioners to combine all of those, and there's never a dull moment.
Philip Polgreen, MD, MPH
I just became a member of IDSA this year, and I find it amazing how supportive IDSA has been to me so far.
Noah Kojima, MD